Animal inflammation-based models of depression and their application to drug discovery

References

• Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet. 1997;349:1498–1504.
   PubMed Web of Science ®Google Scholar
• Cryan JF, Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry. 2004;9:326–357.
   PubMed Web of Science ®Google Scholar
• (APA), A.P.A. Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): APA; 2013.
   Google Scholar
• Schmidt MV, Wang XD, Meijer OC. Early life stress paradigms in rodents: potential animal models of depression? Psychopharmacology (Berl). 2011;214:131–140.
   PubMed Web of Science ®Google Scholar
• Huynh NN, McIntyre RS. What are the implications of the STAR*D trial for primary care? A review and synthesis. Prim Care Companion J Clin Psychiatry. 2008;10:91–96.
   PubMedGoogle Scholar
• Insel TR, Charney DS. Research on major depression: strategies and priorities. JAMA. 2003;289:3167–3168.
   PubMed Web of Science ®Google Scholar
• Wong ML, Licinio J. From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov. 2004;3:136–151.
   PubMed Web of Science ®Google Scholar
• Urani A, Chourbaji S, Gass P. Mutant mouse models of depression: candidate genes and current mouse lines. Neurosci Biobehav Rev. 2005;29:805–828.
   PubMed Web of Science ®Google Scholar
• Nesse RM. Is depression an adaptation? Arch Gen Psychiatry. 2000;57:14–20.
   PubMed Web of Science ®Google Scholar
• Jones I, Blackshaw JK. An evolutionary approach to psychiatry. Aust N Z J Psychiatry. 2000;34:8–13.
   PubMed Web of Science ®Google Scholar
• Koolhaas JM, De Boer SF, Buwalda B, et al. Individual variation in coping with stress: a multidimensional approach of ultimate and proximate mechanisms. Brain Behav Evol. 2007;70:218–226.
   PubMed Web of Science ®Google Scholar
• Overli O, Korzan WJ, Larson ET, et al. Behavioral and neuroendocrine correlates of displaced aggression in trout. Horm Behav. 2004;45:324–329.
   PubMed Web of Science ®Google Scholar
• Overli O, Sorensen C, Pulman KG, et al. Evolutionary background for stress-coping styles: relationships between physiological, behavioral, and cognitive traits in non-mammalian vertebrates. Neurosci Biobehav Rev. 2007;31:396–412.
   PubMed Web of Science ®Google Scholar
• Vindas MA, Johansen IB, Folkedal O, et al. Brain serotonergic activation in growth-stunted farmed salmon: adaption versus pathology. R Soc Open Sci. 2016;3:160030.
   PubMed Web of Science ®Google Scholar
• Keifer J, Summers CH. Putting the “biology” back into “neurobiology”: the strength of diversity in animal model systems for neuroscience research. Front Syst Neurosci. 2016;10:69.
   PubMed Web of Science ®Google Scholar
• Bechtholt AJ, Lucki I. Effects of serotonin-related gene deletion on measures of anxiety, depression, and neurotransmission. In: Roth BL, editor. The serotonin receptors: from molecular pharmacology to human therapeutics. Totowa (NJ): Humana Press; 2006. p. 577–606.
   Google Scholar
• Mohammad F, Ho J, Woo JH, et al. Concordance and incongruence in preclinical anxiety models: systematic review and meta-analyses. Neurosci Biobehav Rev. 2016;68:504–529.
   PubMed Web of Science ®Google Scholar
• Kreiner G, Chmielarz P, Roman A, et al. Gender differences in genetic mouse models evaluated for depressive-like and antidepressant behavior. Pharmacol Rep. 2013;65:1580–1590.
   PubMed Web of Science ®Google Scholar
• Dantzer R, O’Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46–56.
   PubMed Web of Science ®Google Scholar
• Kane MJ, Angoa-Perez M, Briggs DI, et al. Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism. PLoS One. 2012;7:e48975.
   PubMed Web of Science ®Google Scholar
• Angoa-Perez M, Kane MJ, Briggs DI, et al. Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity. J Neurochem. 2012;121:974–984.
   PubMed Web of Science ®Google Scholar
• Angoa-Perez M, Kane MJ, Briggs DI, et al. Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype. ACS Chem Neurosci. 2014;5:908–919.
   PubMed Web of Science ®Google Scholar
• Kalueff AV, Wheaton M, Murphy DL. What’s wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav Brain Res. 2007;179:1–18.
   PubMed Web of Science ®Google Scholar
• Crawley JN. What’s wrong with my mouse? Behavioral phenotyping of transgenic and knockout mice. Hoboken, NJ:John Wiley & Sons; 2007.
   Google Scholar
• Willner P. Behavioural models in psychopharmacology: theoretical, industrial and clinical perspectives. Cambridge, UK:Cambridge University Press; 1991.
   Google Scholar
• Willner P, Mitchell PJ. The validity of animal models of predisposition to depression. Behav Pharmacol. 2002;13:169–188.
   PubMed Web of Science ®Google Scholar
• Anisman H, Matheson K. Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Rev. 2005;29:525–546.
   PubMed Web of Science ®Google Scholar
• Hodes GE, Kana V, Menard C, et al. Neuroimmune mechanisms of depression. Nat Neurosci. 2015;18:1386–1393.
   PubMed Web of Science ®Google Scholar
• Belzung C, Lemoine M. Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression. Biol Mood Anxiety Disord. 2011;1:9.
   PubMedGoogle Scholar
• Monteiro S, Roque S, De Sa-Calcada D, et al. An efficient chronic unpredictable stress protocol to induce stress-related responses in C57BL/6 mice. Front Psychiatry. 2015;6:6.
   PubMed Web of Science ®Google Scholar
• Vollmayr B, Gass P. Learned helplessness: unique features and translational value of a cognitive depression model. Cell Tissue Res. 2013;354:171–178.
   PubMed Web of Science ®Google Scholar
• Vasconcelos M, Stein DJ, De Almeida RM. Social defeat protocol and relevant biomarkers, implications for stress response physiology, drug abuse, mood disorders and individual stress vulnerability: a systematic review of the last decade. Trends Psychiatry Psychother. 2015;37:51–66.
   PubMedGoogle Scholar
• Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22–34.
   PubMed Web of Science ®Google Scholar
• Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996;711:163–174.
   PubMed Web of Science ®Google Scholar
• Capuron L, Ravaud A, Neveu PJ, et al. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry. 2002;7:468–473.
   PubMed Web of Science ®Google Scholar
• Vollmer-Conna U, Fazou C, Cameron B, et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med. 2004;34:1289–1297.
   PubMed Web of Science ®Google Scholar
• Pigeon WR, Hegel M, Unutzer J, et al. Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort? Sleep. 2008;31:481–488.
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, De Fruyt J, Stahl SM. The many faces of fatigue in major depressive disorder. Int J Neuropsychopharmacol. 2005;8:93–105.
   PubMed Web of Science ®Google Scholar
• George LK, Blazer DG, Hughes DC, et al. Social support and the outcome of major depression. Br J Psychiatry. 1989;154:478–485.
   PubMed Web of Science ®Google Scholar
• Bluthe RM, Beaudu C, Kelley KW, et al. Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats. Brain Res. 1995;677:171–176.
   PubMed Web of Science ®Google Scholar
• Remus JL, Dantzer R. inflammation models of depression in rodents: relevance to psychotropic drug discovery. Int J Neuropsychopharmacol. 2016;19:pyw028.
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Janeway CA. Innate immune recognition and control of adaptive immune responses. Semin Immunol. 1998;10:351–353.
   PubMed Web of Science ®Google Scholar
• Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009;22:240–273.
   PubMed Web of Science ®Google Scholar
• Kwidzinski E, Mutlu LK, Kovac AD, et al. Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model. J Neural Transmiss Suppl. 2003;65:29–49.
   PubMedGoogle Scholar
• Bechmann I, Galea I, Perry VH. What is the blood-brain barrier (not)? Trends Immunol. 2007;28:5–11.
   PubMed Web of Science ®Google Scholar
• Shechter R, London A, Schwartz M. Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat Rev Immunol. 2013;13:206–218.
   PubMed Web of Science ®Google Scholar
• Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol. 2012;12:623–635.
   PubMed Web of Science ®Google Scholar
• Weller RO, Engelhardt B, Phillips MJ. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol. 1996;6:275–288.
   PubMed Web of Science ®Google Scholar
• Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 2005;26:485–495.
   PubMed Web of Science ®Google Scholar
• Goldmann J, Kwidzinski E, Brandt C, et al. T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa. J Leukoc Biol. 2006;80:797–801.
   PubMed Web of Science ®Google Scholar
• Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337–341.
   PubMed Web of Science ®Google Scholar
• Aspelund A, Antila S, Proulx ST, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212:991–999.
   PubMed Web of Science ®Google Scholar
• Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330:841–845.
   PubMed Web of Science ®Google Scholar
• Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308:1314–1318.
   PubMed Web of Science ®Google Scholar
• Frost JL, Schafer DP. Microglia: architects of the developing nervous system. Trends Cell Biol. 2016;26:587–597.
   PubMed Web of Science ®Google Scholar
• Tremblay ME, Lowery RL, Majewska AK. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 2010;8:e1000527.
   PubMed Web of Science ®Google Scholar
• Beggs S, Salter MW. SnapShot: microglia in disease. Cell. 2016;165:1294-1294.e1.
   PubMed Web of Science ®Google Scholar
• Chung WS, Welsh CA, Barres BA, et al. Do glia drive synaptic and cognitive impairment in disease? Nat Neurosci. 2015;18:1539–1545.
   PubMed Web of Science ®Google Scholar
• Serrats J, Schiltz JC, Garcia-Bueno B, et al. Dual roles for perivascular macrophages in immune-to-brain signaling. Neuron. 2010;65:94–106.
   PubMed Web of Science ®Google Scholar
• Fitzner D, Schnaars M, Van Rossum D, et al. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci. 2011;124:447–458.
   PubMed Web of Science ®Google Scholar
• Wolf Y, Yona S, Kim KW, et al. Microglia, seen from the CX3CR1 angle. Front Cell Neurosci. 2013;7:26.
   PubMed Web of Science ®Google Scholar
• Wohleb ES, Fenn AM, Pacenta AM, et al. Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice. Psychoneuroendocrinology. 2012;37:1491–1505.
   PubMed Web of Science ®Google Scholar
• Wohleb ES, Powell ND, Godbout JP, et al. Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J Neurosci. 2013;33:13820–13833.
   PubMed Web of Science ®Google Scholar
• McKim DB, Patterson JM, Wohleb ES, et al. Sympathetic release of splenic monocytes promotes recurring anxiety following repeated social defeat. Biol Psychiatry. 2016;79:803–813.
   PubMed Web of Science ®Google Scholar
• Wohleb ES, McKim DB, Shea DT, et al. Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biol Psychiatry. 2014;75:970–981.
   PubMed Web of Science ®Google Scholar
• Wohleb ES, Delpech JC. Dynamic cross-talk between microglia and peripheral monocytes underlies stress-induced neuroinflammation and behavioral consequences. Prog Neuropsychopharmacol Biol Psychiatry. 2017;79:40–48. Forthcoming.
   PubMed Web of Science ®Google Scholar
• Orihuela R, McPherson CA, Harry GJ. Microglial M1/M2 polarization and metabolic states. Br J Pharmacol. 2016;173:649–665.
   PubMed Web of Science ®Google Scholar
• Knuesel I, Chicha L, Britschgi M, et al. Maternal immune activation and abnormal brain development across CNS disorders. Nat Rev Neurol. 2014;10:643–660.
   PubMed Web of Science ®Google Scholar
• Enayati M, Solati J, Hosseini MH, et al. Maternal infection during late pregnancy increases anxiety- and depression-like behaviors with increasing age in male offspring. Brain Research Bulletin. 2012;87:295–302.
   PubMed Web of Science ®Google Scholar
• Christian LM, Franco A, Glaser R, et al. Depressive symptoms are associated with elevated serum proinflammatory cytokines among pregnant women. Brain Behav Immun. 2009;23:750–754.
   PubMed Web of Science ®Google Scholar
• Delpech JC, Madore C, Nadjar A, et al. Microglia in neuronal plasticity: influence of stress. Neuropharmacology. 2015;96:19–28.
   PubMed Web of Science ®Google Scholar
• Couch Y, Anthony DC, Dolgov O, et al. Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia. Brain Behav Immun. 2013;29:136–146.
   PubMed Web of Science ®Google Scholar
• Schleifer SJ, Keller SE, Meyerson AT, et al. Lymphocyte function in major depressive disorder. Arch Gen Psychiatry. 1984;41:484–486.
   PubMed Web of Science ®Google Scholar
• Kronfol Z, House JD, Silva J, et al. Depression, urinary free cortisol excretion and lymphocyte function. Br J Psychiatry. 1986;148:70–73.
   PubMed Web of Science ®Google Scholar
• Kronfol Z, House JD. Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls. Acta Psychiatr Scand. 1989;80:142–147.
   PubMed Web of Science ®Google Scholar
• Nerozzi D, Santoni A, Bersani G, et al. Reduced natural killer cell activity in major depression: neuroendocrine implications. Psychoneuroendocrinology. 1989;14:295–301.
   PubMed Web of Science ®Google Scholar
• Carroll BJ, Martin FI, Davies B. Resistance to suppression by dexamethasone of plasma 11-O.H.C.S. levels in severe depressive illness. Br Med J. 1968;3:285–287.
   PubMed Web of Science ®Google Scholar
• Smith RS. The macrophage theory of depression. Med Hypotheses. 1991;35:298–306.
   PubMed Web of Science ®Google Scholar
• Furtado M, Katzman MA. Examining the role of neuroinflammation in major depression. Psychiatry Res. 2015;229:27–36.
   PubMed Web of Science ®Google Scholar
• Felger JC, Lotrich FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience. 2013;246:199–229.
   PubMed Web of Science ®Google Scholar
• Lotrich FE. Inflammatory cytokine-associated depression. Brain Res. 2015;1617:113–125.
   PubMed Web of Science ®Google Scholar
• Barde YA, Davies AM, Johnson JE, et al. Brain derived neurotrophic factor. Prog Brain Res. 1987;71:185–189.
   PubMed Web of Science ®Google Scholar
• Schinder AF, Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci. 2000;23:639–645.
   PubMed Web of Science ®Google Scholar
• Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677–736.
   PubMed Web of Science ®Google Scholar
• Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007;10:1089–1093.
   PubMed Web of Science ®Google Scholar
• Zhang JC, Wu J, Fujita Y, et al. Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation. Int J Neuropsychopharmacol. 2014;18:1–5.
   Web of Science ®Google Scholar
• Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem. 2002;71:635–700.
   PubMed Web of Science ®Google Scholar
• Lapchak PA, Araujo DM, Hefti F. Systemic interleukin-1 beta decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation. Neuroscience. 1993;53:297–301.
   PubMed Web of Science ®Google Scholar
• Guan Z, Fang J. Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behav Immun. 2006;20:64–71.
   PubMed Web of Science ®Google Scholar
• Chapman TR, Barrientos RM, Ahrendsen JT, et al. Aging and infection reduce expression of specific brain-derived neurotrophic factor mRNAs in hippocampus. Neurobiol Aging. 2012;33:832.e1-832.e14.
   PubMed Web of Science ®Google Scholar
• Zhang JC, Yao W, Hashimoto K. Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets. Curr Neuropharmacol. 2016;14:721–731.
   PubMed Web of Science ®Google Scholar
• Laye S, Gheusi G, Cremona S, et al. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am J Physiol Regul Integr Comp Physiol. 2000;279:R93–98.
   PubMed Web of Science ®Google Scholar
• Parnet P, Kelley KW, Bluthe RM, et al. Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior. J Neuroimmunol. 2002;125:5–14.
   PubMed Web of Science ®Google Scholar
• Andre C, O’Connor JC, Kelley KW, et al. Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration. J Neuroimmunol. 2008;200:90–99.
   PubMed Web of Science ®Google Scholar
• Merali Z, Brennan K, Brau P, et al. Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for “free chow” and “earned” sucrose intake. Psychopharmacology (Berl). 2003;165:413–418.
   PubMed Web of Science ®Google Scholar
• Yirmiya R, Pollak Y, Barak O, et al. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology. 2001;24:531–544.
   PubMed Web of Science ®Google Scholar
• Sammut S, Bethus I, Goodall G, et al. Antidepressant reversal of interferon-alpha-induced anhedonia. Physiol Behav. 2002;75:765–772.
   PubMed Web of Science ®Google Scholar
• Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl). 1997;134:319–329.
   PubMed Web of Science ®Google Scholar
• Grippo AJ, Francis J, Beltz TG, et al. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav. 2005;84:697–706.
   PubMed Web of Science ®Google Scholar
• Goshen I, Kreisel T, Ben-Menachem-Zidon O, et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry. 2008;13:717–728.
   PubMed Web of Science ®Google Scholar
• You Z, Luo C, Zhang W, et al. Pro- and anti-inflammatory cytokines expression in rat’s brain and spleen exposed to chronic mild stress: involvement in depression. Behav Brain Res. 2011;225:135–141.
   PubMed Web of Science ®Google Scholar
• Koo JW, Duman RS. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A. 2008;105:751–756.
   PubMed Web of Science ®Google Scholar
• Eyre HA, Air T, Proctor S, et al. A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression. Prog Neuro-Psychopharmacology Biol Psychiatry. 2015;57:11–16.
   PubMed Web of Science ®Google Scholar
• Graeber MB. Changing face of microglia. Science. 2010;330:783–788.
   PubMed Web of Science ®Google Scholar
• Stevens B, Allen NJ, Vazquez LE, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164–1178.
   PubMed Web of Science ®Google Scholar
• Monier A, Evrard P, Gressens P, et al. Distribution and differentiation of microglia in the human encephalon during the first two trimesters of gestation. J Compar Neurol. 2006;499:565–582.
   PubMed Web of Science ®Google Scholar
• Paolicelli RC, Bolasco G, Pagani F, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456–1458.
   PubMed Web of Science ®Google Scholar
• Cunningham CL, Martinez-Cerdeno V, Noctor SC. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci. 2013;33:4216–4233.
   PubMed Web of Science ®Google Scholar
• Arno B, Grassivaro F, Rossi C, et al. Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex. Nat Commun. 2014;5:5611.
   PubMed Web of Science ®Google Scholar
• Aarum J, Sandberg K, Haeberlein SL, et al. Migration and differentiation of neural precursor cells can be directed by microglia. Proc Natl Acad Sci U S A. 2003;100:15983–15988.
   PubMed Web of Science ®Google Scholar
• Davalos D, Grutzendler J, Yang G, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005;8:752–758.
   PubMed Web of Science ®Google Scholar
• Wake H, Moorhouse AJ, Jinno S, et al. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci. 2009;29:3974–3980.
   PubMed Web of Science ®Google Scholar
• Fourgeaud L, Traves PG, Tufail Y, et al. TAM receptors regulate multiple features of microglial physiology. Nature. 2016;532:240–244.
   PubMed Web of Science ®Google Scholar
• Fontainhas AM, Wang M, Liang KJ, et al. Microglial morphology and dynamic behavior is regulated by ionotropic glutamatergic and GABAergic neurotransmission. PLoS One. 2011;6:e15973.
   PubMed Web of Science ®Google Scholar
• Steiner J, Walter M, Gos T, et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflamm. 2011;8:94.
   PubMed Web of Science ®Google Scholar
• Reus GZ, Fries GR, Stertz L, et al. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience. 2015;300:141–154.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Sarkar R, Berg T, et al. Sadness and mild cognitive impairment as predictors for interferon-alpha-induced depression in patients with hepatitis C. Br J Psychiatry. 2015;206:45–51.
   PubMed Web of Science ®Google Scholar
• Vignau J, Karila L, Costisella O, et al. Hepatitis C, interferon a and depression: main physiopathologic hypothesis. Encephale. 2005;31:349–357.
   PubMed Web of Science ®Google Scholar
• Biesmans S, Meert TF, Bouwknecht JA, et al. Systemic immune activation leads to neuroinflammation and sickness behavior in mice. Mediators Inflamm. 2013;(2013:271359.
   PubMedGoogle Scholar
• Henry CJ, Huang Y, Wynne A, et al. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflamm. 2008;5:15.
   PubMed Web of Science ®Google Scholar
• Hannestad J, DellaGioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 2011;36:2452–2459.
   PubMed Web of Science ®Google Scholar
• Ehret M, Sobieraj DM. Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis. Int J Clin Pract. 2014;68:255–261.
   PubMed Web of Science ®Google Scholar
• Han A, Yeo H, Park MJ, et al. IL-4/10 prevents stress vulnerability following imipramine discontinuation. J Neuroinflammation. 2015;12:197.
   PubMed Web of Science ®Google Scholar
• O’Farrell K, Harkin A. Stress-related regulation of the kynurenine pathway: relevance to neuropsychiatric and degenerative disorders. Neuropharmacology. 2017;112:307–323.
   PubMed Web of Science ®Google Scholar
• Agudelo LZ, Femenia T, Orhan F, et al. Skeletal muscle PGC-1alpha1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell. 2014;159:33–45.
   PubMed Web of Science ®Google Scholar
• Bornstein SR, Schuppenies A, Wong ML, et al. Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Mol Psychiatry. 2006;11:892–902.
   PubMed Web of Science ®Google Scholar
• Purcell RH, Sun B, Pass LL, et al. Maternal stress and high-fat diet effect on maternal behavior, milk composition, and pup ingestive behavior. Physiol Behav. 2011;104:474–479.
   PubMed Web of Science ®Google Scholar
• Perani CV, Slattery DA. Using animal models to study post-partum psychiatric disorders. Br J Pharmacol. 2014;171:4539–4555.
   PubMed Web of Science ®Google Scholar
• Sharma S, Fulton S. Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry. Int J Obes (Lond). 2013;37:382–389.
   PubMed Web of Science ®Google Scholar
• Dong C, Sanchez LE, Price RA. Relationship of obesity to depression: a family-based study. Int J Obes Relat Metab Disord. 2004;28:790–795.
   PubMed Web of Science ®Google Scholar
• Roberts RE, Deleger S, Strawbridge WJ, et al. Prospective association between obesity and depression: evidence from the Alameda County Study. Int J Obes Relat Metab Disord. 2003;27:514–521.
   PubMed Web of Science ®Google Scholar
• Simon GE, Von Korff M, Saunders K, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry. 2006;63:824–830.
   PubMed Web of Science ®Google Scholar
• Riemer S, Maes M, Christophe A, et al. Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome. J Affect Disord. 2010;123:173–180.
   PubMed Web of Science ®Google Scholar
• Conquer JA, Tierney MC, Zecevic J, et al. Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment. Lipids. 2000;35:1305–1312.
   PubMed Web of Science ®Google Scholar
• Tsuchimine S, Saito M, Kaneko S, et al. Decreased serum levels of polyunsaturated fatty acids and folate, but not brain-derived neurotrophic factor, in childhood and adolescent females with depression. Psychiatry Res. 2015;225:187–190.
   PubMed Web of Science ®Google Scholar
• Conklin SM, Manuck SB, Yao JK, et al. High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosom Med. 2007;69:932–934.
   PubMed Web of Science ®Google Scholar
• Adams PB, Lawson S, Sanigorski A, et al. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids. 1996;31 Suppl:S157–161.
   PubMed Web of Science ®Google Scholar
• Chiu CC, Frangou S, Chang CJ, et al. Associations between n-3 PUFA concentrations and cognitive function after recovery from late-life depression. Am J Clin Nutr. 2012;95:420–427.
   PubMed Web of Science ®Google Scholar
• Nieves D, Moreno JJ. Effect of arachidonic and eicosapentaenoic acid metabolism on RAW 264.7 macrophage proliferation. J Cell Physiol. 2006;208:428–434.
   PubMed Web of Science ®Google Scholar
• Brock TG, Peters-Golden M. Activation and regulation of cellular eicosanoid biosynthesis. ScientificWorldJournal. 2007;7:1273–1284.
   PubMed Web of Science ®Google Scholar
• Harizi H, Corcuff JB, Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol Med. 2008;14:461–469.
   PubMed Web of Science ®Google Scholar
• Calder PC. Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Braz J Med Biol Res. 2003;36:433–446.
   PubMed Web of Science ®Google Scholar
• Babcock T, Helton WS, Espat NJ. Eicosapentaenoic acid (EPA): an antiinflammatory omega-3 fat with potential clinical applications. Nutrition. 2000;16:1116–1118.
   PubMed Web of Science ®Google Scholar
• Adam O, Beringer C, Kless T, et al. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int. 2003;23:27–36.
   PubMed Web of Science ®Google Scholar
• Ohnishi H, Saito Y. Eicosapentaenoic acid (EPA) reduces cardiovascular events: relationship with the EPA/arachidonic acid ratio. J Atheroscler Thromb. 2013;20:861–877.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Djuric Z, Sen A, et al. Biomarkers for personalizing omega-3 fatty acid dosing. Cancer Prev Res (Phila). 2014;7:1011–1022.
   PubMed Web of Science ®Google Scholar
• Song C, Li X, Leonard BE, et al. Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats. J Lipid Res. 2003;44:1984–1991.
   PubMed Web of Science ®Google Scholar
• Ren Q, Ma M, Ishima T, et al. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress. Proc Natl Acad Sci U S A. 2016;113:E1944–1952.
   PubMed Web of Science ®Google Scholar
• Lin PY, Chang CH, Chong MF, et al. Polyunsaturated fatty acids in perinatal depression: a systematic review and meta-analysis. Biol Psychiatry. 2017. Forthcoming.
   Google Scholar
• Messamore E, Almeida DM, Jandacek RJ, et al. Polyunsaturated fatty acids and recurrent mood disorders: phenomenology, mechanisms, and clinical application. Prog Lipid Res. 2017;66:1–13.
   PubMed Web of Science ®Google Scholar
• McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171–179.
   PubMed Web of Science ®Google Scholar
• De Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6:463–475.
   PubMed Web of Science ®Google Scholar
• Pariante CM. Depression, stress and the adrenal axis. J Neuroendocrinol. 2003;15:811–812.
   PubMed Web of Science ®Google Scholar
• Herbert J, Goodyer IM, Grossman AB, et al. Do corticosteroids damage the brain? J Neuroendocrinol. 2006;18:393–411.
   PubMed Web of Science ®Google Scholar
• Dinan TG. Glucocorticoids and the genesis of depressive illness. A psychobiological model. Br J Psychiatry. 1994;164:365–371.
   PubMed Web of Science ®Google Scholar
• Harmer CJ, Goodwin GM, Cowen PJ. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry. 2009;195:102–108.
   PubMed Web of Science ®Google Scholar
• Zunszain PA, Anacker C, Cattaneo A, et al. Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:722–729.
   PubMed Web of Science ®Google Scholar
• Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007;21:374–383.
   PubMed Web of Science ®Google Scholar
• Pace TW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun. 2007;21:9–19.
   PubMed Web of Science ®Google Scholar
• Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000;23:477–501.
   PubMed Web of Science ®Google Scholar
• Carpenter WT Jr., Bunney WE Jr. Adrenal cortical activity in depressive illness. Am J Psychiatry. 1971;128:31–40.
   PubMed Web of Science ®Google Scholar
• McClure DJ. The diurnal variation of plasma cortisol levels in depression. J Psychosom Res. 1966;10:189–195.
   PubMed Web of Science ®Google Scholar
• Luby JL, Heffelfinger A, Mrakotsky C, et al. Alterations in stress cortisol reactivity in depressed preschoolers relative to psychiatric and no-disorder comparison groups. Arch Gen Psychiatry. 2003;60:1248–1255.
   PubMed Web of Science ®Google Scholar
• Bhagwagar Z, Hafizi S, Cowen PJ. Increase in concentration of waking salivary cortisol in recovered patients with depression. Am J Psychiatry. 2003;160:1890–1891.
   PubMed Web of Science ®Google Scholar
• Bhagwagar Z, Hafizi S, Cowen PJ. Increased salivary cortisol after waking in depression. Psychopharmacology (Berl). 2005;182:54–57.
   PubMed Web of Science ®Google Scholar
• Cowen PJ. Not fade away: the HPA axis and depression. Psychol Med. 2010;40:1–4.
   PubMed Web of Science ®Google Scholar
• Juruena MF, Cleare AJ, Papadopoulos AS, et al. Different responses to dexamethasone and prednisolone in the same depressed patients. Psychopharmacology (Berl). 2006;189:225–235.
   PubMed Web of Science ®Google Scholar
• Nemeroff CB, Widerlov E, Bissette G, et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 1984;226:1342–1344.
   PubMed Web of Science ®Google Scholar
• Nemeroff CB, Krishnan KR, Reed D, et al. Adrenal gland enlargement in major depression. A computed tomographic study. Arch Gen Psychiatry. 1992;49:384–387.
   PubMed Web of Science ®Google Scholar
• Wolkowitz OM, Reus VI. Treatment of depression with antiglucocorticoid drugs. Psychosom Med. 1999;61:698–711.
   PubMed Web of Science ®Google Scholar
• Murphy BE, Dhar V, Ghadirian AM, et al. Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol. 1991;11:121–126.
   PubMed Web of Science ®Google Scholar
• Murphy BE, Filipini D, Ghadirian AM. Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486. J Psychiatry Neurosci. 1993;18:209–213.
   PubMed Web of Science ®Google Scholar
• Murphy BE, Ghadirian AM, Dhar V. Neuroendocrine responses to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy. Can J Psychiatry. 1998;43:279–286.
   PubMed Web of Science ®Google Scholar
• Wolkowitz OM, Reus VI, Manfredi F, et al. Ketoconazole administration in hypercortisolemic depression. Am J Psychiatry. 1993;150:810–812.
   PubMed Web of Science ®Google Scholar
• Anand A, Malison R, McDougle CJ, et al. Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report. Biol Psychiatry. 1995;37:338–340.
   PubMed Web of Science ®Google Scholar
• Sovner R, Fogelman S. Ketoconazole therapy for atypical depression. J Clin Psychiatry. 1996;57:227–228.
   PubMed Web of Science ®Google Scholar
• Thakore JH, Dinan TG. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiatry. 1995;37:364–368.
   PubMed Web of Science ®Google Scholar
• Holsboer F. CRHR1 antagonists as novel treatment strategies. CNS Spectr. 2001;6:590–594.
   PubMedGoogle Scholar
• Keck ME, Holsboer F. Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides. 2001;22:835–844.
   PubMed Web of Science ®Google Scholar
• Abautret-Daly A, Dempsey E, Parra-Blanco A, et al. Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta Neuropsychiatr. 2017;1–22.
   PubMedGoogle Scholar
• Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. PNAS. 2011;108:16050–16055.
   PubMed Web of Science ®Google Scholar
• Savignac HM, Kiely B, Dinan TG, et al. Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil. 2014;26:1615–1627.
   PubMed Web of Science ®Google Scholar
• Savignac HM, Tramullas M, Kiely B, et al. Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behav Brain Res. 2015;287:59–72.
   PubMed Web of Science ®Google Scholar
• Selkrig J, Wong P, Zhang X, et al. Metabolic tinkering by the gut microbiome: implications for brain development and function. Gut Microbes. 2014;5:369–380.
   PubMed Web of Science ®Google Scholar
• Bercik P, Denou E, Collins J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011;141:599-609, 609 e591-593.
   Web of Science ®Google Scholar
• Sudo N, Chida Y, Aiba Y, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004;558:263–275.
   PubMed Web of Science ®Google Scholar
• Zheng P, Zeng B, Zhou C, et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry. 2016;21:786–796.
   PubMed Web of Science ®Google Scholar
• Clarke G, Grenham S, Scully P, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry. 2013;18:666–673.
   PubMed Web of Science ®Google Scholar
• Heijtz RD, Wang S, Anuar F, et al. Normal gut microbiota modulates brain development and behavior. PNAS. 2011;108:3047–3052.
   PubMed Web of Science ®Google Scholar
• Neufeld K-AM, Kang N, Bienenstock J, et al. Effects of intestinal microbiota on anxiety-like behavior. Communicat Integr Biol. 2011;4:492–494.
   PubMedGoogle Scholar
• Nishino R, Mikami K, Takahashi H, et al. Commensal microbiota modulate murine behaviors in a strictly contamination-free environment confirmed by culture-based methods. Neurogastroenterol Motil. 2013;25:521–528.
   PubMed Web of Science ®Google Scholar
• Burokas A, Arboleya S, Moloney RD, et al. Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry. 2017. Forthcoming.
   PubMedGoogle Scholar
• Yang C, Fujita Y, Ren Q, et al. Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice. Sci Rep. 2017;7:45942.
   PubMed Web of Science ®Google Scholar
• Jiang H, Ling Z, Zhang Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186–194.
   PubMed Web of Science ®Google Scholar
• Slykerman RF, Thompson J, Waldie KE, et al. Antibiotics in the first year of life and subsequent neurocognitive outcomes. Acta Paediatr. 2017;106:87–94.
   PubMed Web of Science ®Google Scholar
• Gariepy G, Wang J, Lesage A, et al. Obesity and the risk of disability in a 12-year cohort study: the role of psychological distress. Soc Psychiatry Psychiatr Epidemiol. 2011;46:1173–1179.
   PubMed Web of Science ®Google Scholar
• Addolorato G, Capristo E, Stefanini GF, et al. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol. 1997;32:1013–1021.
   PubMed Web of Science ®Google Scholar
• Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74:720–726.
   PubMed Web of Science ®Google Scholar
• Messaoudi M, Violle N, Bisson JF, et al. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes. 2011;2:256–261.
   PubMed Web of Science ®Google Scholar
• Steenbergen L, Sellaro R, Van Hemert S, et al. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun. 2015;48:258–264.
   PubMed Web of Science ®Google Scholar
• Benton D, Williams C, Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr. 2007;61:355–361.
   PubMed Web of Science ®Google Scholar
• Bharwani A, Mian MF, Surette MG, et al. Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress. BMC Med. 2017;15:7.
   PubMed Web of Science ®Google Scholar
• Kelly JR, Allen AP, Temko A, et al. Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav Immun. 2017;61:50–59.
   PubMed Web of Science ®Google Scholar
• Abildgaard A, Elfving B, Hokland M, et al. Probiotic treatment reduces depressive-like behaviour in rats independently of diet. Psychoneuroendocrinology. 2017;79:40–48.
   PubMed Web of Science ®Google Scholar
• Maes M, Kubera M, Leunis JC, et al. Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J Affect Disord. 2012;141:55–62.
   PubMed Web of Science ®Google Scholar
• Ohland CL, Kish L, Bell H, et al. Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psychoneuroendocrinology. 2013;38:1738–1747.
   PubMed Web of Science ®Google Scholar
• Zhu CB, Blakely RD, Hewlett WA. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology. 2006;31:2121–2131.
   PubMed Web of Science ®Google Scholar
• Cai W, Khaoustov VI, Xie Q, et al. Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression. J Hepatol. 2005;42:880–887.
   PubMed Web of Science ®Google Scholar
• Clark KJ, Boczek NJ, Ekker SC. Stressing zebrafish for behavioral genetics. Rev Neurosci. 2011;22:49–62.
   PubMed Web of Science ®Google Scholar
• Pavlidis M, Theodoridi A, Tsalafouta A. Neuroendocrine regulation of the stress response in adult zebrafish, Danio rerio. Prog Neuropsychopharmacol Biol Psychiatry. 2015;60:121–131.
   PubMed Web of Science ®Google Scholar
• Steenbergen PJ, Richardson MK, Champagne DL. Patterns of avoidance behaviours in the light/dark preference test in young juvenile zebrafish: a pharmacological study. Behav Brain Res. 2011;222:15–25.
   PubMed Web of Science ®Google Scholar
• Alsop D, Vijayan MM. Development of the corticosteroid stress axis and receptor expression in zebrafish. Am J Physiol Regul Integr Comp Physiol. 2008;294:R711–719.
   PubMed Web of Science ®Google Scholar
• Abreu MS, Koakoski G, Ferreira D, et al. Diazepam and fluoxetine decrease the stress response in zebrafish. PLoS One. 2014;9:e103232.
   PubMed Web of Science ®Google Scholar
• Chakravarty S, Reddy BR, Sudhakar SR, et al. Chronic unpredictable stress (CUS)-induced anxiety and related mood disorders in a zebrafish model: altered brain proteome profile implicates mitochondrial dysfunction. PLoS One. 2013;8:e63302.
   PubMed Web of Science ®Google Scholar
• Marcon M, Herrmann AP, Mocelin R, et al. Prevention of unpredictable chronic stress-related phenomena in zebrafish exposed to bromazepam, fluoxetine and nortriptyline. Psychopharmacology. 2016;233:3815–3824.
   PubMed Web of Science ®Google Scholar